As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
|
|
|
|
|
Experts from Rutgers Cancer Institute of New Jersey will be presenting a variety of key data in several types of cancer, including leukemia, lymphoma, melanoma and breast, lung and kidney cancer at the 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held virtually from June 4 to 8. A total of 16 presentations including 13 abstracts, two educational sessions and one clinical science symposium have been accepted which will focus on a variety of cancer types as well as racial disparities in cancer risk and patient care. Read more for highlights and a full list of Rutgers Cancer Institute presentations.
|
|
$2.7 Million NIH Grant Supports Collaboration in Pancreatic Cancer Research |
|
|
|
The University of North Carolina in collaboration with Rutgers Cancer Institute of New Jersey has received a $2.7 million grant (1R01CA247652-01A1) from the National Cancer Institute to support pancreatic cancer exploration. Rutgers Cancer Institute Director and Senior Vice President of Oncology Services for RWJBarnabas Health, Steven K. Libutti, MD, FACS, is an investigator on the project, which will evaluate whether use of minibeam radiation therapy, in contrast to conventional broad beam radiation therapy, will help the delivery of nanoparticle cancer drugs into pancreatic cancer tumor models. Learn more
|
|
Identifying Potential Treatment for Triple Negative Breast Cancer |
|
|
|
Investigators at Rutgers Cancer Institute of New Jersey and Rutgers New Jersey Medical School discovered a phage display-based approach to halt tumor growth that could be used to treat triple-negative breast cancer. Authors of the study include Fernanda I. Staquicini, PhD, who conducted the work while a resident member of Rutgers Cancer Institute, and assistant professor of radiation oncology at Rutgers NJMS. This is in addition to senior author Wadih Arap, MD, PhD, director of Rutgers Cancer Institute at University Hospital and Renata Pasqualini, PhD, resident member of Rutgers Cancer Institute and chief of the Division of Cancer Biology at NJMS. The findings have been published online in the scientific journal eLife. Learn more
|
|
Addressing LGBTQ+ Cancer Concerns |
|
|
|
A person with cancer who identifies as lesbian, gay, bisexual, transgender or non-binary may have unique concerns about communicating with their cancer care team, navigating the healthcare system and coping with their diagnosis. Joan Hogan, MSW, LCSW, OSW-C, manager of Social Work Services at Rutgers Cancer Institute of New Jersey who is currently a doctorate of clinical social work (DSW) candidate at Rutgers School of Social Work where her research focus is oncology and the transgender patient experience, calls attention to the healthcare challenges and barriers faced by this community during Pride Month and explains how health care professionals are becoming better allies. Learn more
|
|
Indoor Tanning and Cancer Concerns |
|
|
|
According to the American Cancer Society, the most common type of cancer nationwide is skin cancer. There is substantial evidence that indoor tanning is associated with increased risk of skin cancer and public health officials have become increasingly concerned. Carolyn J. Heckman, PhD, co-leader of the Cancer Prevention and Control Program at Rutgers Cancer Institute and an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is corresponding author of a viewpoint paper published in JAMA Dermatology which addresses the importance of increasing efforts to limit indoor tanning among minors. Learn more
|
|
|
|
|
|
|
